[{"address1": "11 Hurley Street", "city": "Cambridge", "state": "MA", "zip": "02141", "country": "United States", "phone": "617 401 9000", "website": "https://www.editasmedicine.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops reni-cel, a clinical development gene-edited medicine to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors in collaboration with Bristol Myers Squibb Company (\u0093BMS\u0094) through its wholly owned subsidiary, Juno Therapeutics, Inc. It also collaboration and licensing agreement with Immatics to combine gamma-delta T cell adoptive cell therapies and gene editing for the treatment of cancer. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 246, "companyOfficers": [{"maxAge": 1, "name": "Dr. Gilmore  O'Neill M.D.", "age": 59, "title": "President, CEO & Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 1040919, "exercisedValue": 0, "unexercisedValue": 39656}, {"maxAge": 1, "name": "Dr. Linda C. Burkly Ph.D.", "age": 66, "title": "Executive VP & Chief Scientific Officer", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 522442, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Feng  Zhang Ph.D.", "title": "Co-Founder & Scientific Advisory Board Member", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. George McDonald Church Ph.D.", "age": 70, "title": "Co-Founder & Scientific Advisory Board Member", "yearBorn": 1954, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory  Whitehead", "title": "Executive VP and Chief Technical & Quality Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Cristi  Barnett", "title": "Senior VP of Corporate Communications & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlene  Stern J.D., Ph.D.", "title": "Executive VP & General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Linea  Aspesi", "age": 54, "title": "Executive VP & Chief People Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caren  Deardorf", "age": 59, "title": "Executive VP and Chief Commercial & Strategy Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy  Parison", "age": 38, "title": "Senior VP of Finance", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.3, "open": 1.31, "dayLow": 1.24, "dayHigh": 1.3106, "regularMarketPreviousClose": 1.3, "regularMarketOpen": 1.31, "regularMarketDayLow": 1.24, "regularMarketDayHigh": 1.3106, "payoutRatio": 0.0, "beta": 1.873, "forwardPE": -0.5319149, "volume": 1139813, "regularMarketVolume": 1139813, "averageVolume": 3869401, "averageVolume10days": 1728510, "averageDailyVolume10Day": 1728510, "bid": 0.9432, "ask": 1.6, "bidSize": 1, "askSize": 2, "marketCap": 103720384, "fiftyTwoWeekLow": 1.12, "fiftyTwoWeekHigh": 7.41, "priceToSalesTrailing12Months": 3.2097661, "fiftyDayAverage": 1.5089, "twoHundredDayAverage": 2.976625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -131160648, "profitMargins": 0.0, "floatShares": 82622805, "sharesOutstanding": 82976304, "sharesShort": 13149670, "sharesShortPriorMonth": 17438018, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1585, "heldPercentInsiders": 0.00317, "heldPercentInstitutions": 0.66174006, "shortRatio": 1.74, "shortPercentOfFloat": 0.20040001, "impliedSharesOutstanding": 82976304, "bookValue": 1.623, "priceToBook": 0.7701787, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -237092992, "trailingEps": -2.88, "forwardEps": -2.35, "enterpriseToRevenue": -4.059, "enterpriseToEbitda": 0.563, "52WeekChange": -0.8282967, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 1.25, "targetHighPrice": 8.0, "targetLowPrice": 1.0, "targetMeanPrice": 3.75, "targetMedianPrice": 3.5, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 269912992, "totalCashPerShare": 3.253, "ebitda": -233111008, "totalDebt": 35032000, "quickRatio": 3.706, "currentRatio": 3.746, "totalRevenue": 32314000, "debtToEquity": 26.09, "revenuePerShare": 0.392, "returnOnAssets": -0.35522, "returnOnEquity": -0.981, "grossProfits": -166932992, "freeCashflow": -121089000, "operatingCashflow": -210284000, "revenueGrowth": -0.49, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -1.12276, "financialCurrency": "USD", "symbol": "EDIT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1454509800000, "postMarketChangePercent": 4.0, "postMarketPrice": 1.3, "postMarketChange": 0.05, "regularMarketChange": -0.049999952, "regularMarketDayRange": "1.24 - 1.3106", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3869401, "fiftyTwoWeekLowChange": 0.13, "fiftyTwoWeekLowChangePercent": 0.116071425, "fiftyTwoWeekRange": "1.12 - 7.41", "fiftyTwoWeekHighChange": -6.16, "fiftyTwoWeekHighChangePercent": -0.831309, "fiftyTwoWeekChangePercent": -82.82967, "earningsTimestamp": 1741208700, "earningsTimestampStart": 1746534600, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1723032000, "earningsCallTimestampEnd": 1723032000, "isEarningsDateEstimate": true, "regularMarketChangePercent": -3.8461502, "regularMarketPrice": 1.25, "marketState": "CLOSED", "shortName": "Editas Medicine, Inc.", "longName": "Editas Medicine, Inc.", "epsTrailingTwelveMonths": -2.88, "epsForward": -2.35, "epsCurrentYear": -1.53057, "priceEpsCurrentYear": -0.8166892, "fiftyDayAverageChange": -0.25890005, "fiftyDayAverageChangePercent": -0.17158197, "twoHundredDayAverageChange": -1.726625, "twoHundredDayAverageChangePercent": -0.5800613, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1743204150, "regularMarketTime": 1743192001, "exchange": "NMS", "messageBoardId": "finmb_252050056", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Editas Medicine", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]